Announcements Trials
Browse Landscape

Phase

Phase 2 33Phase 1/2 7Phase 3 2Phase 2/3 2Phase 1 2Phase 4 1

Status

Unknown 1Completed 1

Sponsor Class

INDUSTRY 13OTHER 2NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Stomach Neoplasms 1Colorectal Neoplasms 1

Interventions

Cisplatin 294Radiotherapy 230Fluorouracil 201Cyclophosphamide 191Capecitabine 183Docetaxel 167Gemcitabine 165Oxaliplatin 162Carboplatin 161Paclitaxel 152Leucovorin 122Drug Therapy 119Dexamethasone 119Doxorubicin 112Etoposide 99Bevacizumab 91Cytarabine 87Vincristine 83Irinotecan 81Rituximab 77Epirubicin 71Prednisone 65Radiosurgery 63Methotrexate 62Surgical Procedures, Operative 61Radiation 60Radiotherapy, Intensity-Modulated 57Neoadjuvant Therapy 53Lenalidomide 52Letrozole 51

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × OTHER × Ramucirumab × Clear all
NCT03520946 2024-08-09

RAMTAS

Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest

Phase 3 Completed
430 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT02934464 2021-09-13

ARMANI

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase 3 Unknown
280 enrolled
Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡